CompaniesAvant Diagnostics

Avant Diagnostics

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

51

By Phase

PHASE2: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2016

2017

2018

2019

2020

Today

Hover over trial bars to see details

Recent Trials

NCT03078101Collaborator

EMPRA (EMPagliflozin and RAs in Kidney Disease)

PHASE2Completed

51 participants

Started: Apr 15, 2017 · Completed: Aug 7, 2019

Funding History (14)

8-K

Apr 9, 2019

8-K

Mar 26, 2019

8-K

Feb 6, 2019

8-K

Sep 24, 2018

8-K

Sep 14, 2018

8-K

Aug 28, 2018

8-K

Jun 14, 2018

D

Jun 13, 2018

8-K/A

Jun 13, 2018

8-K

May 25, 2018

Related Companies

Oncbiomune

acquired